BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12680150)

  • 1. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.
    Kubota T; Egawa T; Otani Y; Furukawa T; Saikawa Y; Yoshida M; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2003; 23(1B):583-7. PubMed ID: 12680150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy.
    Nakamura R; Saikawa Y; Kubota T; Kumagai A; Kiyota T; Ohashi M; Yoshida M; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2006; 26(2B):1433-7. PubMed ID: 16619555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers.
    Abe S; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M
    Anticancer Res; 1999; 19(5C):4581-6. PubMed ID: 10650814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.
    Iwahashi M; Nakamori M; Nakamura M; Noguchi K; Ueda K; Nakatani Y; Ojima T; Ishida K; Naka T; Yamaue H
    Anticancer Res; 2005; 25(5):3453-9. PubMed ID: 16101163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of chemosensitivity test for advanced colorectal cancer.
    Kabeshima Y; Kubota T; Watanabe M; Hasegawa H; Furukawa T; Kitajima M
    Anticancer Res; 2002; 22(5):3033-7. PubMed ID: 12530038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay.
    Noguchi K; Iwahashi M; Tani M; Nakamura M; Nakamori M; Nakatani Y; Ueda K; Ishida K; Naka T; Ojima T; Hotta T; Mizobata S; Yamaue H
    Anticancer Res; 2005; 25(2A):931-7. PubMed ID: 15868930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
    Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
    Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
    Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.
    Saikawa Y; Kubota T; Furukawa T; Suto A; Watanabe M; Kumai K; Ishibiki K; Kitajima M
    Jpn J Cancer Res; 1994 Jul; 85(7):762-5. PubMed ID: 8071118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
    Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
    Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination].
    Nakamura R; Saikawa Y; Wada N; Yoshida M; Kubota T; Kumai K; Kitajima M; Kitagawa Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1827-31. PubMed ID: 18030017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
    Yonemura Y; Bandou E; Sawa T; Yoshimitsu Y; Endou Y; Sasaki T; Sugarbaker PH
    Eur J Surg Oncol; 2006 Aug; 32(6):661-5. PubMed ID: 16621433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
    Ahn MS; Kang SY; Lee HW; Jeong SH; Park JS; Lee KJ; Cho YK; Han SU; Lee SY; Lim HY; Choi JH
    Onkologie; 2013; 36(7-8):421-6. PubMed ID: 23921761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of contrast-enhanced CT of the peritoneum to evaluate efficacy of neoadjuvant chemotherapy for peritoneal dissemination in an advanced gastric cancer case].
    Ohtani M; Takayama S; Ogata N; Sekine C; Nimura H; Tsutsumi J; Kashimura H; Sano Y; Inoue Y; Aoki T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1837-40. PubMed ID: 8937495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
    Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
    Kim SG; Hwang SH
    World J Surg Oncol; 2016 Apr; 14():102. PubMed ID: 27039375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
    Yano M; Tsujinaka T; Shiozaki H; Inoue M; Doki Y; Taniguchi M; Murata A; Monden M
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):139-42. PubMed ID: 9464342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination].
    Ishikawa T; Mizuno K; Togashi T; Watanabe K; Seki K; Ohta H; Yoshida T; Kamimura T
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):469-72. PubMed ID: 15853212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.